Small molecule amiloride modulates oncogenic RNA alternative splicing to devitalize human cancer cells

Jan-Gowth Chang1, Den-Mei Yang, Wen-Hsin Chang

  • 1Department of Medical Research, University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. jgchang@ms.kmuh.org.tw

Plos One
|June 23, 2011
PubMed

Insights

Amiloride normalizes cancer cell RNA splicing by affecting splicing factors and signaling pathways. This leads to reduced cancer cell invasion, migration, and survival, offering a potential new cancer therapeutic strategy.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Drug Discovery

Background:

  • Alternative splicing generates diverse protein isoforms, and its dysregulation is linked to cancer malignancy, including chemo-resistance and invasion.
  • Identifying small molecules that modulate RNA splicing is crucial for developing novel cancer therapeutics.

Purpose of the Study:

  • To screen for small molecules that can modulate RNA splicing in human hepatocellular carcinoma (HCC) cells.
  • To investigate the molecular mechanisms by which amiloride affects RNA splicing and cancer cell phenotypes.
  • To explore the therapeutic potential of amiloride in cancer treatment.

Main Methods:

  • Screening of small molecules for RNA splicing modulation in Huh-7 HCC cells.
  • Proteomic analysis to identify changes in splicing factors and signaling pathway proteins.
  • Global exon array analysis to detect splicing pattern alterations.
  • Cellular functional assays to assess invasion, migration, cell cycle, and DNA integrity.

Main Results:

  • Amiloride selectively "normalized" aberrant splicing of BCL-X, HIPK3, and RON/MISTR1 transcripts in Huh-7 cells.
  • Amiloride treatment led to hypo-phosphorylation of splicing factor SF2/ASF and altered levels of other SR proteins.
  • Proteomic analysis revealed amiloride-induced changes in kinase/phosphatase activity affecting splicing factor phosphorylation, which were reversible with a PP1 inhibitor.
  • Global exon array identified widespread splicing changes in 551 genes, impacting various cellular functions.
  • Amiloride treatment impaired cancer cell invasion, migration, cell cycle progression, and induced DNA degradation.
  • Similar splicing alterations and cytotoxic effects were observed in other cancer cells, but not significantly in normal cells.

Conclusions:

  • Amiloride acts as a novel RNA splicing modulator, distinct from its pH-altering effects.
  • The mechanism involves down-regulation of specific kinases and up-regulation of phosphatases impacting splicing factor phosphorylation.
  • Amiloride-induced splicing normalization and subsequent cellular defects present a promising avenue for cancer therapeutics.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...